Regulatory oversight : FDA-regulated options (503B compounding, direct manufacturer purchases, and brand-name drugs) ensure the highest safety and quality
However, we do recommend that patients use this no more than 80-90 days per year
FDA-approved branded GLP-1 medications Wegovy and Ozempic (semaglutide, Novo Nordisk), Mounjaro and Zepbound (tirzepatide, Eli Lilly), Saxenda (liraglutide), Rybelsus (oral semaglutide), Trulicity (dulaglutide), Victoza (liraglutide) underwent the SUSTAIN, STEP, SURPASS, and SURMOUNT trial programs and are reviewed by the FDA as finished drug products
Fontana L, Partridge L, Longo VD
In this study, we provide evidence for regulated ATP release from enteroendocrine L-cells and demonstrate functional purinergic signalling from L-cells to enterocyte and neuronal targets within the colonic mucosa
June 22, 2024